-

Levi & Korsinsky, LLP: Institutional Investors in Navan Face Alleged Portfolio Losses After IPO

Notice to Pension Funds, Asset Managers, and Fiduciaries

NEW YORK--(BUSINESS WIRE)--Institutional investors holding positions in Navan, Inc. (Nasdaq: NAVN) acquired pursuant or traceable to the Company's October 31, 2025 initial public offering may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Shares purchased at the $25 IPO price have declined to as low as $9.20 before the lawsuit was filed. The Court has set April 24, 2026 as the deadline to apply for lead plaintiff appointment.

Fiduciary Obligations and Recovery Options

Pension funds, mutual funds, and asset managers that acquired NAVN shares in the IPO owe fiduciary duties to their beneficiaries to evaluate all avenues for loss recovery. The Private Securities Litigation Reform Act of 1995 favors institutional investors as lead plaintiffs, recognizing their capacity to oversee complex securities litigation on behalf of a broader class.

Key considerations for fiduciaries include:

- Institutions that purchased NAVN shares at $25 in the October 2025 IPO and held through December 16, 2025 experienced per-share losses of approximately $12.10 based on the post-disclosure closing price

- The PSLRA presumes that the investor with the largest financial interest should serve as lead plaintiff, a role well suited to institutional holders

- Lead plaintiff appointment carries no additional financial obligation; counsel fees are paid from any recovery obtained for the class

- Fiduciaries who fail to evaluate participation in securities recoveries may face questions from beneficiaries regarding their oversight responsibilities

- The lawsuit asserts strict liability and negligence claims under §§11, 12, and 15 of the Securities Act of 1933, which do not require proof of fraudulent intent

Portfolio Impact Assessment

The action contends that Navan's Offering Documents omitted material information about a 39% surge in sales and marketing expenses during the quarter ending October 31, 2025, the same day as the IPO. This omission allegedly rendered statements about the Company's "rapid growth" and key financial metrics misleading to investors who relied on the Offering Documents when making allocation decisions.

Contact us for institutional recovery options or call (212) 363-7500.

Case Summary

The class action was filed in the United States District Court for the Northern District of California on behalf of all persons and entities that purchased Navan common stock issued pursuant or traceable to the IPO.

"Institutional investors play a critical role in securities class actions. Their participation strengthens the class and ensures that fiduciary interests are represented by parties with the resources and standing to oversee litigation involving alleged IPO disclosure failures of this magnitude." -- Joseph E. Levi, Esq.

INSTITUTIONAL INVESTOR REPRESENTATION -- Levi & Korsinsky, LLP provides sophisticated counsel to institutional investors evaluating lead plaintiff opportunities. The firm has recovered hundreds of millions of dollars. Ranked among ISS Top 50 for seven consecutive years.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NASDAQ:NAVN

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

OI Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into O-I Glass (OI)

NEW YORK--(BUSINESS WIRE)--Guidance of $1.65 to $1.90 per share. Actual Q1 2026 adjusted EPS was $0.05 and earnings guidance was reduced to $1.00 - $1.50 per share. Actual Q2 2026 adjusted EPS was $0.09. O-I Glass (NYSE: OI) shares fell approximately 15% on July 29, 2026 after the Company reported second quarter results and cut its full-year outlook. If you lost money on OI shares, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at jle...

PSN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Parsons Corporation (PSN)

NEW YORK--(BUSINESS WIRE)--Parsons Corporation (NYSE: PSN) reported a net loss of $15 million, a $70 million year-over-year reduction; shares fell 35%. If you lost money on Parsons stock, click here to submit your loss information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.When Parsons reported its Q1 results on April 29, 2026, it reaffirmed previous guidance on the back of a net income of $53 million, a reduced performance o...

PHAT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Phathom Pharmaceuticals, Inc. (PHAT)

NEW YORK--(BUSINESS WIRE)--Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) shareholders took losses after the Company lowered its full-year 2026 revenue guidance to $310 million–$325 million from its previously issued $320 million–$345 million range, falling below Wall Street consensus estimates of approximately $332 million. If you suffered a loss on your Phathom Pharmaceuticals investment, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via...
Back to Newsroom